Trial of Anifrolumab in Active Systemic Lupus ErythematosusEric F. Morand, Raj Tummala, Richard Furie et al.|New England Journal of Medicine|2019Cited by 1.3k
<i>MUC5B</i> Promoter Variant and Rheumatoid Arthritis with Interstitial Lung DiseasePierre‐Antoine Juge, Annick Clément, Pascal Richette et al.|New England Journal of Medicine|2018Cited by 501
Rheumatic disorders associated with immune checkpoint inhibitors in patients with cancer—clinical aspects and relationship with tumour response: a single-centre prospective cohort studyMarie Kostine, Thierry Schaeverbeke, L. Rouxel et al.|Annals of the Rheumatic Diseases|2017Cited by 302
OX40 Ligand Contributes to Human Lupus Pathogenesis by Promoting T Follicular Helper ResponseC. Jacquemin, Patrick Blanco, Nathalie Schmitt et al.|Immunity|2015Cited by 223
Platelet CD154 Potentiates Interferon-α Secretion by Plasmacytoid Dendritic Cells in Systemic Lupus ErythematosusP. Duffau, Patrick Blanco, Julien Sénéschal et al.|Science Translational Medicine|2010Cited by 219